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Targeting genes for
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A procedure is described that directs the self-induced
deletion of DNA sequences as they pass through the
male germ line of mice. The testes-specific promoter
from the angiotensin-converting enzyme gene was used
to drive expression of the Cre-recombinase gene. Cre
was linked to the selectable marker Neor, and the two
genes flanked with loxP elements. This cassette was tar-
geted to the Hoxa3 gene in mouse ES cells that were in
turn used to generate chimeric mice. In these chimeras,
somatic cells derived from the ES cells retained the cas-
sette, but self-excision occurred in all ES-cell-derived
sperm.
Received April 16, 1999; revised version accepted May 3,
1999.
The paradigm for targeted germ-line modification of a
mammalian genome was established 12 years ago
(Thomas and Capecchi 1987). An alteration introduced
in vitro into a cloned gene is transferred by homologous
recombination to its chromosomal target in a pluripo-
tent embryo-derived stem (ES) cell. Cells containing the
modification are placed in an embryonic environment,
allowed to grow, differentiate, and contribute to the
germ line of the host organism. Limitations imposed by
the transformation and recombination efficiencies of
mammalian cells require that the alteration of interest
be linked physically to a selectable genetic marker, typi-
cally a gene encoding drug resistance under transcrip-
tional control of a constitutive promoter/enhancer ele-
ment. This operational requirement can have unpredict-
able consequences in vivo, such as misregulation of
adjacent genes (Olson et al. 1996) or the attenuation of
expression of the gene of interest (Colledge et al. 1995;
Meyers et al. 1998). Thus, the elimination of the marker
may be desirable and, for technical reasons, is generally
performed through use of site-specific recombinase sys-
tems such as Cre/loxP (Sternberg and Hamilton 1981) or
FLP/FRT (Broach and Hicks 1980). To facilitate this pro-
cess, we have devised a self-excision procedure that
takes advantage of a testes-specific promoter to drive ex-
pression of the Cre recombinase. The marker gene,
linked to Cre, survives selection in cultured cells, but is
removed along with Cre as both are passed through the
male germ line.
The strategy behind this protocol is illustrated in Fig-
ure 1: The intragenic promoter of the murine angioten-
sin-converting enzyme, tACE (shown to initiate tran-
scription only during spermatogenesis; Langford et al.
1991), directs expression of Cre; tACE–Cre is linked to
the selectable marker gene Neor, and the two genes
tACE–Cre/Neor, are flanked with loxP sites. This cas-
sette, referred to as ACN, is targeted by homologous re-
combination to a specific locus in a murine ES cell. Cells
containing the appropriate chromosomal recombinant
are inserted into a blastocyst-stage mouse embryo that
develops into a chimeric animal, containing cells from
both the host blastocyst and the cassette-containing ES
cells. If the chimerism extends to the germ line of an
adult male, some fraction of the sperm will be ES-cell
derived. During spermatogenesis the tACE promoter in-
duces expression of the Cre-recombinase gene, the ACN
cassette is excised, and a single loxP element remains at
the chromosomal locus. Progeny from these sperm
should represent two classes of paternal transmission: (1)
those containing a wild-type paternal chromosome,
originating either from the nontargeted chromosome in
the heterozygous ES cells or from non-ES (i.e., host)-de-
rived cells; and (2) those containing a loxP insertion in
the paternal chromosome.
Results and Discussion
The experimental design used to test this protocol is
illustrated in Figure 2. Two features of the ACN cassette
are noteworthy: Neor is located 38 of the tACE–Cre gene,
such that transcription of Neor should not result in tran-
scriptional readthrough of Cre; and the Cre gene con-
tains an intron to prevent in-frame translation and sub-
sequent self-excision in bacteria. We inserted the ACN
cassette into a genomic clone of the mouse Hoxa3 gene
(McGinnis et al. 1984) and transfected the targeting vec-
tor into mouse ES cells. We clonally isolated 144 cell
lines that survived positive/negative selection and dem-
onstrated by Southern transfer analysis that 20 con-
tained the ACN cassette integrated into one of the en-
dogenous Hoxa3 loci.
Three of the recombinant ES cell lines were used to
generate 13 male chimeric mice that, in turn, sired 138
ES cell-derived progeny (determined by coat color). All
progeny were genotyped by a PCR-based assay that could
distinguish between the three potential Hoxa3 alleles:
wild type, ACN, and loxP (Fig. 3a). Figure 3b shows such
an assay, comparing DNA isolated from the parental ES
cell line, one recombinant ES cell line, tail biopsies from
a chimeric male, and six of his agouti progeny. The re-
combinant ES cells and the chimera-derived tails are het-
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erozygous for the wild-type and ACN-containing alleles,
whereas the F1 progeny are either wild type or heterozy-
gous for the loxP allele. A summary of the genotypes of
all 138 progeny, shown in Table 1, demonstrates that
tACE–Cre mediated germ line excision of the ACN cas-
sette in all cases.
Although self-excision was complete at the level of
spermatogenesis, it was also restricted to the testes. Tis-
sues from chimeric males that transmitted the loxP al-
lele were genotyped and, with the exception of the tes-
tes, were heterozygous for wild-type and ACN alleles
(Fig. 3c). Testes, which were mosaic for the two mutant
Hoxa3 alleles, include multiple cell types, only two of
which, the elongating spermatids and the spermatozoa,
should contain the loxP allele (Langford et al. 1991).
A similar protocol has been used to generate mice car-
rying a loxP insertion in the Hoxd3 gene (data not
shown), and it should be applicable to a vast number of
loci. The tACE promoter is inactive in somatic cells
when integrated at independent ectopic sites (Langford
et al. 1991). It also appears refractory to activation when
integrated at random loci in ES cells, even when linked
to a transcriptionally active Neor gene. Were the tACE
promoter expressed frequently following integration in
ES cells, the capacity of DNA carrying the self-excision
cassette to generate stable transformants would be
greatly reduced, but this is not the case (data not shown).
It remains possible, however, that if the cassette were
targeted to a transcriptionally active locus, the Cre pro-
tein could be translated from readthrough mRNA tran-
scribed into the cassette. Under such conditions, it
would be necessary to custom-design a cassette contain-
ing transcription insulators (Pikaart et al. 1998) or to
place ACN in a transcriptional orientation opposite that
of the target locus.
Figure 1. Testes-specific self-excision. (A) A selectable marker
gene, Neor, with a constitutive promoter, is transferred by ho-
mologous recombination to a specific locus in a mouse ES cell.
The Neor gene is linked to a Cre gene that is under transcrip-
tional control of the tACE promoter, and the two genes are
flanked with loxP sites (P); the entire cassette, ACN, is intro-
duced by gene targeting to a specific locus in a mouse ES cell. (B)
ES cells, heterozygous for an allele containing the integrated
cassette, are injected into wild-type mouse blastocysts and the
blastocysts allowed to develop; the resulting animals are chi-
meric for wild-type (host-derived) cells (white) and ES-derived
cells (black). (C) Male chimeric animals will transmit through
their sperm one of two alleles of the locus of interest: wild-type
(white) or mutant (gray); if self-excision has occurred the mu-
tant allele will be marked only by a loxP site, the final product
of the testes-specific self-excision reaction. Figure 2. Targeting of a self-excision cassette to Hoxa3. (A)
Self-excision cassette, ACN: The testes-specific elements from
the mouse ACE gene (black arrow) are placed 58 of the modified
Cre structural gene (Gu et al. 1993) (red), followed, 38, with the
minimal polyadenylation signal from HSV–TK (Thomas and Ca-
pecchi 1987) (white box); an intron, derived from the SV40 t-
antigen gene (white box), is inserted into the Cre gene; the Neor
gene (blue) is controlled by a promoter from the mouse RNA
polymerase II gene (black arrow) and followed also by the HSV–
TK poly(A) site (white box). The 58 and 38 ends of this cassette
contain loxP sites (P). (B) Gene targeting at Hoxa3: (Top line)
The targeting vector pRVa3ACN; the vector contains 11 kb of
mouse genomic DNA into which the self-excision cassette
ACN has been inserted in the homeodomain of Hoxa3 (McGin-
nis et al. 1984); the genomic sequences are linked to the HSV–
TK gene (dark gray) and all are contained on a pUC-based plas-
mid backbone (light gray); the ACN cassette contains at its 58
end an SstI site (S), used as a marker for homologous integration
of the cassette at the Hoxa3 gene; (second line) the wild-type
Hoxa3 locus; (bottom line) the predicted structure of the recom-
binant Hoxa3ACN allele. The 58 flanking probe used to detect
recombination is indicated, and the diagnostic SstI-generated
DNA fragments delineated beneath each locus. Yellow boxes
designate Hoxa3 exons; other SstI sites in the vector are not
indicated. (C) Southern transfer analysis: DNA from the paren-
tal cell line (ES) and the homologous recombinant ES lines used
to generate mice was restricted with SstI; radiolabeled DNA
probe is depicted in B.
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Potential uses for a self-excision cassette such as the
one described here are numerous. In the generation of
knockout animals, this technology should see immedi-
ate application. The possibility that a marker gene may
affect phenotype unpredictably has already prompted re-
moval of such sequences prior to phenotypic analysis
(Hasty et al. 1991; Meyers et al. 1998). Although alter-
native recombinase-based excision methods do exist,
they are often accompanied with operational inconve-
niences. For example, removal of sequences during the
growth of ES cells (Gu et al. 1993) requires additional
selection and/or screening. Not only is there a time and
labor consideration involved in such manipulation, but
the pluripotency of ES cells can be adversely affected by
prolonged growth in culture. Sequence deletion in the
animal relies either on the expression of the recombinase
in the fertilized eggs of animals carrying a loxP-flanked
gene (Araki et al. 1995), the mating of such animals with
a Cre-expressing mouse (Schwenk et al. 1995), or the use
of ES cells containing a Cre-expressing transgene
(O’Gorman et al. 1997). All methods require additional
breeding and/or technical expertise, and thus prolong by
several months the time required for analysis. This prag-
matic advantage should also be realized in the generation
of chromosomal rearrangements typically medi-
ated by Cre-catalyzed recombination (Ramrez-So-
lis et al. 1995; Smith et al. 1995; He´rault et al.
1998) or in the condensation of tandem repeats
resulting from the random integration of trans-
genes following pronuclear injection (Garrick et
al. 1998). Linkage of tACE–Cre to a loxP site de-
fining the desired deletion endpoint should greatly
simplify these chromosomal engineering pro-
cesses.
This technique should prove especially valuable
in the generation of mice harboring conditional-
mutant alleles (Rossant and McMahon 1999). The
creation of such animals often takes advantage of
either the Cre/loxP or FLP/FRT recombination
systems to create genetic deletions regulated by
the restricted spatial or temporal expression of the
appropriate recombinase (Gu et al. 1994; Meyers
et al. 1998). The recombinogenic elements, loxP
or FRT, must first be introduced into the genome
by linkage to a selectable marker gene. Because it
is essential that the ground state of such experi-
ments be wild type, it is imperative that the
marker gene not influence the expression of the
target gene. If the two recombinase systems were
employed in the same animal, for example, the
self-excising cassette expressing FLP and deletion
elements responding to the conditional expression
of Cre, such a requirement could be met.
Self-excision strategies will undoubtedly find
use outside the realm of genetically modified
mice. New strains of agricultural crops are now
equipped with ‘terminator’ genes to limit the
propagation of proprietary traits (Service 1998). A
self-excision mechanism activated only in the
germ line would provide a single-step method to
restrict those traits to a single, founding generation and
may reduce the threat of unintended transmission of ge-
netic traits to nontarget species. There are also proposals
to attempt in utero human gene therapy as a means of
correcting genetic deficiencies (Wadman 1998). Because
such protocols will induce genetic changes in embryonic
cells, including those that may colonize the germ line,
they have raised both moral and pragmatic objections
(Ewbank 1998; McLaren 1998). If, however, such modi-







1d-7 3 23 0 26
1h-9 9 37 0 32
1f-9 1 7 0 13
Total 13 67 0 71
Male chimeric animals derived from three cell lines were mated
with C57Bl/6 females. DNA was extracted from tails of all
agouti pups and was genotyped as described in Materials and
Methods and the legend to Fig. 3. The number of animals in
each genotype is indicated.
Figure 3. Genetic transmission of Hoxa3 alleles. (A) The PCR-based
genotyping of the three Hoxa3 alleles: Primer 1 (p1) is from the Hoxa3
intron; primer 2 (p2) is from coding exon 2-derived sequences (antisense);
primer 3 (p3) is from the Neor gene. Predicted sizes are indicated; color
coding is as in Fig. 2. (B) Genotyping of DNA: DNA is from wild-type ES
cells (ES), recombinant ES cell line, 1h-9, tail biopsies from a chimeric
male, x3227, generated from 1h-9, and tail tissue from F1 progeny of the
chimera; amplified DNA was electrophoresed through agarose and stained
with ethidium bromide. Sizes correspond to those listed in a. (C) Absence
of excision in somatic tissue. A single chimeric male derived from cell line
1h-9 was sacrificed at 8 weeks of age. DNA extracted from each of the
indicated tissues was analyzed by PCR as in B. Analysis of a second chi-
mera showed an identical result.
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fications were linked with a germ line-expressed recom-
binase and flanked with recombinogenic elements, the
challenges to such modifications may be removed along
with the intervening DNA (Capecchi 1999).
Materials and methods
Vector construction
The self-excision cassette was assembled into the bacterial plasmid pBS
(Stratagene) using standard cloning methods. The tACE promoter se-
quences are nucleotides 495–1194; the Cre gene includes the entire pro-
tein-coding domain from pMC1–Cre (Gu et al. 1993) followed by the
minimal poly(A) sequence from the HSV–TK gene (Thomas and Capecchi
1987); intron sequences from the SV40 t-antigen gene, nucleotides 4637–
4572, were amplified by PCR and inserted between codons 283 and 284
of Cre; the Neor gene is an 873-bp PstI–BamHI fragment isolated from
pMClNeo–poly(A) (Thomas and Capecchi 1987); the promoter includes
bases 1–713 from the mouse RNA polymerase II large subunit gene; the
34-bp minimal loxP sites are in parallel orientation at each end of the
cassette. Murine Hoxa3 sequences were isolated from a l phage library
constructed in this laboratory of genomic DNA isolated from ES cells.
Sequences used for the targeting vector extend from a Sau3AI site, 2.2 kb
upstream of the ATG in exon 1 to an EcoRI site 5.5 kb 38 of the TGA in
exon 2. ACN was inserted into the BglII site in the homeodomain in exon
2. An 8-bp EcoRV-containing oligonucleotide linker was also inserted at
the Eco47III site in exon l. This introduces a premature stop codon,
creating an allele of Hoxa3 to be used in future studies of this locus.
ES cells: transformation, screening, and blastocyst injection
The targeting vector pRVa3ACN was introduced in linear form by elec-
troporation into RI ES cells (Nagy et al. 1993) that were subsequently
selected for resistance to G418 and FIAU. Approximately 2 × 107 cells
were subjected to electroporation and 144 drug-resistant colonies iso-
lated. DNA was extracted from cells of each clone and subjected to analy-
sis by Southern transfer under previously described conditions (Thomas
and Capecchi 1987). Homologous recombination was verified following
digestion with two separate restriction endonucleases and hybridization
with three individual probes. No rearrangements other than the pre-
dicted homologous recombination reaction were seen nor were any ho-
mologous recombination events accompanied by detectable random in-
tegration of vector sequences. Cells from clones identified as heterozy-
gous at the Hoxa3 locus were injected into C57Bl/6-derived blastocysts
that were allowed to come to term. Chimeric progeny were identified by
coat color, and those males estimated to contain >80% ES cell contribu-
tion were mated with C57Bl/6 females.
Tissue and cell genotype analysis
DNA was extracted from tail biopsies of chimeric males and their prog-
eny, as well as from tissues isolated from euthanized chimeric animals,
and resuspended in TE buffer. Approximately 1 µg of DNA was dissolved
in 40 µl of a PCR lysis buffer (Spyropoulos and Capecchi 1994), denatured
at 95°C for 5 min, and quick-chilled on ice. Five microliters of the de-
natured DNA solution was amplified for 30 cycles in a 25-µl reaction
mixture under previously described reaction conditions and cycling pa-
rameters (Deng et al. 1993). Primer sequences were as follows: Primer 1,
58-GCTCTTCCTCTCTGTGTCCTG-38, represents sequences 58 of the
splice acceptor site in the Hoxa3 intron (J. Greer and K. Thomas, un-
publ.); primer 2, 58-CGAATGCATAGAATTCAGATAGCC-38, is anti-
sense sequence from Hoxa3, nucleotides 849–826 (McGinnis et al. 1984);
primer 3, 58-GCCTGCTTGCCGATTATCATGG-38, is from the sense
strand of the Neor gene, nucleotides 2121–2142. Amplified products were
analyzed by electrophoresis through 3% NuSieve 3:1 agarose (FMC). Fig-
ure 3b shows products from single, 25-µl reactions; Figure 3c contains
pools of 8 amplification reactions.
GenBank accession numbers
SV40 t-antigen (JO2400); loxP (M10287); RNA polymerase II
large subunit (M14101); ACE (M61094); Neo (V00618).
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